Trial Profile
A Phase 1, Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2011
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 16 Feb 2011 New trial record